Latest Articles

Publication Date
A family medicine expert shares what travelers need to know to stay safe from serious illnesses - newscentermaine.com

A family medicine expert shares what travelers need to know to stay safe from serious illnesses newscentermaine.com

Published: April 2, 2026, 2:40 p.m.
Updated NICE fertility guidance includes specific path for endometriosis - Pulse Today

Updated NICE fertility guidance includes specific path for endometriosis Pulse Today

Published: April 2, 2026, 11:33 a.m.
Dangerous Rises in Gender Based Violence, Healthcare Neglect and Lack of Special Needs Services Demand Organised Collective Fightback - People Before Profit

Dangerous Rises in Gender Based Violence, Healthcare Neglect and Lack of Special Needs Services Demand Organised Collective Fightback People Before Profit

Published: April 2, 2026, 10:13 a.m.
Bindi Irwin speaks out on 'indescribable pain' from 'invisible disease' in heartbreaking health update - Newsner

Bindi Irwin speaks out on 'indescribable pain' from 'invisible disease' in heartbreaking health update Newsner

Published: April 2, 2026, 8:20 a.m.
Governments call on general practice for pelvic pain help - Medical Republic

Governments call on general practice for pelvic pain help Medical Republic

Published: April 2, 2026, 4:42 a.m.
Governments call on general practice for pelvic pain help - medicalrepublic.com.au

Governments call on general practice for pelvic pain help medicalrepublic.com.au

Published: April 2, 2026, 4:42 a.m.
Single-Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non-Pregnant, Non-Lactating Premenopausal Female Subjects Under Fasting Conditions.

Elagolix is a short-acting oral gonadotropin-releasing hormone antagonist utilized for treating endometriosis-associated pain by rapidly suppressing gonadotropins and estradiol. Although well characterized in Western populations, clinical data regarding its use …

Published: April 2, 2026, midnight
Endometrioid Versus Seromucinous Borderline Ovarian Tumors: Divergent Molecular Signatures and a Shared Role as Precursors to Endometrioid Carcinoma.

Endometrioid borderline tumors (EBTs) and seromucinous borderline tumors (SMBTs) are rare ovarian neoplasms with distinct histologic features. However, the molecular profiles of EBTs and SMBTs remain incompletely characterized. We performed …

Published: April 2, 2026, midnight
Adenomyosis Pathophysiology, Diagnostic Advances, and Therapeutic Options.

Adenomyosis is a heterogeneous, nonmalignant uterine disorder characterized by ectopic endometrium within the myometrium, leading to abnormal uterine bleeding, dysmenorrhea, chronic pelvic pain, and subfertility. Once considered a disease of …

Published: April 2, 2026, midnight
Thoracic endometriosis in an inoperable patient.

In this case report, we present a case of a woman in her 30s who was diagnosed with thoracic endometriosis presenting as a large pulmonary mass. Hormonal treatment progestin (synthetic …

Published: April 2, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!